Impact on patients

Session 5: Different reimbursement strategies of anti-CGRP monoclonal antibodies in Nordic countries – a clinical or political decision?

Elena Ruiz de la Torre

Executive Director, Past President, European Migraine and Headache Alliance EMHA, Belgium